Literature DB >> 7965639

Trends in risk behavior and HIV seroprevalence in heterosexual injection drug users in San Francisco, 1986-1992.

J K Watters1.   

Abstract

We examine changes and stability in risk behaviors and HIV-1 seroprevalence among heterosexual injection drug users (IDUs) over 13 cross-sectional surveys, 1986-1992. Interviews (n = 5,956) were conducted with IDUs in street settings and drug detoxification clinics over 6.5 years, and respondents were tested for HIV-1 antibody. Trends in use of condoms and bleach and HIV seroprevalence were assessed using multiple logistic and linear regression analyses. The percentage of time condoms were reportedly used during intercourse among men increased from 4.5% to 31.0%. Among the declining population of IDUs who reported needle sharing, reported use of bleach increased from 3% to 89%. Significant changes in use of bleach 100% of the time were reported: 29.8% in 1988, 52.8% in 1990, and 40.0% in 1992. HIV seroprevalence doubled from 7% in 1986 to 14% in 1987. Post-1987 fluctuations in HIV seroprevalence were not significant. Significant changes in risk behaviors among IDUs were reported over the study period. These changes coincided with the implementation of HIV prevention in San Francisco, including outreach programs, HIV testing and counseling, bleach distribution, and syringe exchange. The moderate and stable rate of HIV seroprevalence beginning in 1987 parallels self-reported reductions in risk behavior.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7965639

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr (1988)        ISSN: 0894-9255


  13 in total

1.  HIV transmission and the cost-effectiveness of methadone maintenance.

Authors:  G S Zaric; P G Barnett; M L Brandeau
Journal:  Am J Public Health       Date:  2000-07       Impact factor: 9.308

2.  Predictors and prevention of nonfatal overdose among street-recruited injection heroin users in the San Francisco Bay Area, 1998-1999.

Authors:  K H Seal; A H Kral; L Gee; L D Moore; R N Bluthenthal; J Lorvick; B R Edlin
Journal:  Am J Public Health       Date:  2001-11       Impact factor: 9.308

3.  HIV prevalence, risk behaviors, health care use, and mental health status of transgender persons: implications for public health intervention.

Authors:  K Clements-Nolle; R Marx; R Guzman; M Katz
Journal:  Am J Public Health       Date:  2001-06       Impact factor: 9.308

4.  HIV seroprevalence among homeless and marginally housed adults in San Francisco.

Authors:  Marjorie J Robertson; Richard A Clark; Edwin D Charlebois; Jacqueline Tulsky; Heather L Long; David R Bangsberg; Andrew R Moss
Journal:  Am J Public Health       Date:  2004-07       Impact factor: 9.308

5.  Changes in blood-borne infection risk among injection drug users.

Authors:  Shruti H Mehta; Jacqueline Astemborski; Gregory D Kirk; Steffanie A Strathdee; Kenrad E Nelson; David Vlahov; David L Thomas
Journal:  J Infect Dis       Date:  2011-01-31       Impact factor: 5.226

6.  Trends in HIV seroprevalence, AIDS and prevention policy among intravenous drug users and men who have sex with men, before and after 1990 in Austria.

Authors:  F Piribauer; W Duer
Journal:  Eur J Epidemiol       Date:  1998-10       Impact factor: 8.082

7.  Reduction in Needle Sharing Among Seattle-Area Injection Drug Users Across 4 Surveys, 1994-2013.

Authors:  Richard D Burt; Hanne Thiede
Journal:  Am J Public Health       Date:  2015-12-21       Impact factor: 9.308

8.  Outreach in natural settings: the use of peer leaders for HIV prevention among injecting drug users' networks.

Authors:  C A Latkin
Journal:  Public Health Rep       Date:  1998-06       Impact factor: 2.792

9.  Preventing HIV in injection drug users: choosing the best mix of interventions for the population.

Authors:  Amy R Wilson; James G Kahn
Journal:  J Urban Health       Date:  2003-09       Impact factor: 3.671

10.  Attitudes about prescribing take-home naloxone to injection drug users for the management of heroin overdose: a survey of street-recruited injectors in the San Francisco Bay Area.

Authors:  Karen H Seal; Moher Downing; Alex H Kral; Shannon Singleton-Banks; Jon-Paul Hammond; Jennifer Lorvick; Dan Ciccarone; Brian R Edlin
Journal:  J Urban Health       Date:  2003-06       Impact factor: 3.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.